These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21813089)

  • 21. Implementing physician buy-in to practice guidelines.
    Kaplan JG; Lamprey J
    Med Interface; 1995 Aug; 8(8):64-6, 68. PubMed ID: 10144773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doctors and the drug industry: reader feedback.
    Warrier R; Houghton B
    Am J Med; 2005 Oct; 118(10):1175-6; author reply 1176. PubMed ID: 16194656
    [No Abstract]   [Full Text] [Related]  

  • 23. Academic perspectives on dietary supplements use: the need for new guidelines.
    Grollman AP
    Thromb Res; 2005; 117(1-2):185-92; discussion 201-7. PubMed ID: 16143370
    [No Abstract]   [Full Text] [Related]  

  • 24. Doctors and the drug industry: reader feedback.
    Nardone DA
    Am J Med; 2005 Oct; 118(10):1176-7; author reply 1177. PubMed ID: 16194658
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality care and practice variation: the roles of practice guidelines and public profiles.
    Margo CE
    Surv Ophthalmol; 2004; 49(3):359-71. PubMed ID: 15110672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conflict of interest.
    Mamalis N
    J Cataract Refract Surg; 2011 Mar; 37(3):431-2. PubMed ID: 21333864
    [No Abstract]   [Full Text] [Related]  

  • 27. When does expert witness testimony constitute a violation of the ACR Code of Ethics? The role of the ACR Committee on Ethics.
    Berlin L; Hoffman TR; Shields WF; Cox J;
    J Am Coll Radiol; 2006 Apr; 3(4):252-8. PubMed ID: 17412056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redefining appropriate use of antibiotics.
    Gums JG
    Am Fam Physician; 2004 Jan; 69(1):35, 39-40. PubMed ID: 14727818
    [No Abstract]   [Full Text] [Related]  

  • 29. Responding to requests from adult patients for neuroenhancements: guidance of the ethics, law and humanities committee.
    Racine E; Forlini C
    Neurology; 2010 May; 74(19):1555-6; author reply 1556. PubMed ID: 20458078
    [No Abstract]   [Full Text] [Related]  

  • 30. How to introduce clinical practice guidelines.
    Loveday BP; Windsor JA
    N Z Med J; 2008 Jun; 121(1275):7-10. PubMed ID: 18551148
    [No Abstract]   [Full Text] [Related]  

  • 31. More on conflict of interest from a clinical professor of neurology in private practice at a headache center.
    Rapoport AM
    Headache; 2006 Jun; 46(6):1020-1. PubMed ID: 16732851
    [No Abstract]   [Full Text] [Related]  

  • 32. The details are in the field.
    Schwab AP
    Am J Bioeth; 2010 Jan; 10(1):19-21. PubMed ID: 20077330
    [No Abstract]   [Full Text] [Related]  

  • 33. Practice standards: legal implications.
    Burroughs JT
    Leg Med; 1992; ():179-90. PubMed ID: 1306279
    [No Abstract]   [Full Text] [Related]  

  • 34. Public disclosure of conflicts of interest: moving the policy debate forward.
    Campbell EG
    Arch Intern Med; 2010 Apr; 170(8):667. PubMed ID: 20421548
    [No Abstract]   [Full Text] [Related]  

  • 35. U.S. statin guidelines: expensive but not necessarily effective.
    Barry HC; Hoffman JR
    Am Fam Physician; 2007 May; 75(10):1453-4, 1456. PubMed ID: 17555139
    [No Abstract]   [Full Text] [Related]  

  • 36. [Conflicts of interest: should we lower our guard?].
    De Fiore L
    Recenti Prog Med; 2015 Jul; 106(7):305-7. PubMed ID: 26228720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical practice and pharmaceutical industry: an always difficult relationship].
    Mastai R
    Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851
    [No Abstract]   [Full Text] [Related]  

  • 38. [Strategies for drug promotion].
    Polonuer JL
    Medicina (B Aires); 2005; 65(4):373-6. PubMed ID: 16193722
    [No Abstract]   [Full Text] [Related]  

  • 39. Bridging the major prospective National Eye Institute-sponsored glaucoma clinical trials and clinical practice.
    De Moraes CG; Ritch R; Liebmann JM
    J Glaucoma; 2011 Jan; 20(1):1-2. PubMed ID: 20436371
    [No Abstract]   [Full Text] [Related]  

  • 40. The devil in the detail(ing).
    Morreim H
    Am J Bioeth; 2010 Jan; 10(1):15-7. PubMed ID: 20077328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.